Alan’s son Dylan (11) is affected by Multiple Sulfatase Deficiency. Alan is passionate about promoting and supporting MSD research, especially translational research, in every way possible. Alan is a patient champion for a REMEDi4ALL repurposing programme on MSD. Alan is a member of the steering committee, patient board and the lysosomal disorder committees of MetabERN. Alan led MSDAF to fund 14 MSD research projects. Potential therapies are now on the horizon for this once much neglected disorder.
